2020 Tufts CSDD study examines relationship between investigative site personnel diversity and study participant diversity.
Maria I. Florez
Advertisement
Articles by Maria I. Florez
The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Global Breast Cancer Trials Show Progress in Diversity, But Gaps Remain
2
Bringing Clinical Trials Into the Digital Era with eConsent
3
ACT Brief: AI Innovations, Vision Trial Breakthroughs, and a Major Industry Acquisition
4
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
